D. Bretherton-watt et al., Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population, BR J CANC, 85(2), 2001, pp. 171-175
There is increasing evidence that vitamin D can protect against breast canc
er. The actions of vitamin D are mediated via the vitamin D receptor (VDR).
We have investigated whether polymorphisms in the VDR gene are associated
with altered breast cancer risk in a UK Caucasian population. We recruited
241 women following a negative screening mammogram and 181 women with known
breast cancer. The VDR polymorphism Bsml, an intronic 3' gene variant, was
significantly associated with increased breast cancer risk: odds ratio bb
vs BB genotype = 2.32 (95% Cl, 1.23-4.39). The Bsml polymorphism was in lin
kage disequilibrium with a candidate translational control site, the variab
le length poly (A) sequence in the 3' untranslated region. Thus, the 'L' po
ly (A) variant was also associated with a similar breast cancer risk. A 5'
VDR gene variant, Fokl, was not associated with breast cancer risk. Further
investigations into the mechanisms of interactions of the VDR with other e
nvironmental and/or genetic influences to alter breast cancer risk may lead
to a new understanding of the role of vitamin D in the control of cellular
and developmental pathways. (C) 2001 Cancer Research Campaign http://www.b
jcancer.com.